Tuberculosis, a contagious disease with significant implications for public health, disproportionately affects the most vulnerable populations on a global scale. These vulnerable groups, characterized by a heightened risk of tuberculosis and hindered access to healthcare due to socio-economic disadvantages or marginalization, are particularly impacted. Litvinjenko, Magwood, Wu, and Wei (2023) conducted a comprehensive overview of reviews aiming to evaluate the prevalence and incidence of tuberculosis among 12 vulnerable populations worldwide. Systematic and scoping reviews, specifically addressing the occurrence of active tuberculosis within these populations, were included in the study. To address gaps in evidence, primary or secondary database studies were utilized. The study meticulously compiled characteristics and outcome data related to the burden of tuberculosis, incorporating prevalence ratios and incidence rate ratios. The findings were synthesized narratively. It’s worth noting that this trial is registered with PROSPERO under the registration number CRD42022324421.1

Read more here.

References

  1. Litvinjenko, S., Magwood, O., Wu, S., & Wei, X. (2023). Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews. The Lancet Infectious Diseases, 23(12), 1395–1407. https://doi.org/10.1016/s1473-3099(23)00372-9

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred